Teva Asks High Court to Block Generics Ahead of Copaxone Ruling

, The Litigation Daily

   | 0 Comments

Teva Pharmaceuticals v. Sandoz could usher in a new era of deference to trial judges in patent cases. But Teva's lawyers reminded the Supreme Court on Monday that there's real money at stake in the case as well.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202650139278

Thank you!

This article's comments will be reviewed.